Cobra Biologics and Symbiosis Pharmaceutical Services have been awarded a collaborative grant of £1.9m from Innovate UK.
Follow @TheManufacturer The two UK pharmaceutical firms have been awarded a collaborative grant of £1.9m from Innovate UK – image courtesy of Depositphotos. This grant will be used by the companies to establish commercial viral vector manufacturing capabilities within the UK as part of their joint investment project (costing £4.8m…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login

